Laparoscopic Vs. Open Lower Mediastinal Lymphadenectomy for Siewert Type II/III Adenocarcinoma of Esophagogastric Junction: an Exploratory, Observational, Prospective, IDEAL Stage 2b Cohort Study (CLASS-10 Study)
Shuangxi Li,Xiangji Ying,Fei Shan,Yongning Jia,Zhemin Li,Kan Xue,Rulin Miao,Yinkui Wang,Zhaode Bu,Xiangqian Su,Ziyu Li,Jiafu Ji
DOI: https://doi.org/10.21147/j.issn.1000-9604.2022.04.08
2022-01-01
Chinese Journal of Cancer Research
Abstract:Objective:This study aims to verify the feasibility and efficacy of laparoscopic lower mediastinal lymphadenectomy for Siewert type II/III adenocarcinoma of esophagogastric junction (AEG).Setting:An exploratory, observational, prospective, cohort study will be carried out under the Idea, Development, Exploration, Assessment and Long-term Follow-up (IDEAL) framework (stage 2b).Participants:The study will recruit 1,036 patients with cases of locally advanced AEG (Siewert type II/III, clinical stage cT2-4aN0-3M0), and 518 will be assigned to either the laparoscopy group or the open group.Interventions:Patients will receive lower mediastinal lymphadenectomy along with either total or proximal gastrectomy.Primary and secondary outcome measures:The primary endpoint is the number of lower mediastinal lymph nodes retrieved, and the secondary endpoints are the surgical safety and prognosis, including intraoperative and postoperative lower-mediastinal-lymphadenectomy-related morbidity and mortality, rate of rehospitalization, R0 resection rate, 3-year local recurrence rate, and 3-year overall survival.Conclusions:The study will provide data for the guidance and development of surgical treatment strategies for AEG.Trial registration number:The study has been registered in ClinicalTrials.gov (No. NCT04443478).